Skip to main content
Erschienen in: International Ophthalmology 2/2023

17.08.2022 | Original Paper

Trephination and silicone tube intubation in the treatment of canalicular obstruction

verfasst von: Berna Sahan, Ferda Ciftci

Erschienen in: International Ophthalmology | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the efficacy of trephination and monocanalicular/bicanalicular silicone tube use depending on the number of affected canaliculi in patients with canalicular obstruction.

Methods

This retrospective study included 46 eyes of 36 patients who underwent trephination and silicone tube intubation performed by a single experienced oculoplastic surgeon due to canalicular obstruction between 2005 and 2020. Monocanalicular silicone tube was applied to patients with one canalicular obstruction, and bicanalicular silicone tube was applied to those with the upper and lower canalicular involvement of the same eye. Canalicular obstructions were divided into groups according to their localization as proximal, middle, and distal. The silicone tubes were kept in place for at least 5 months after the operation, and the follow-up duration of the patients was at least 12 months.

Results

Twenty (55.6%) patients were female and 16 (44.4%) were male. The mean age was 15.82 ± 7.02 years in the treatment success group and 28.87 ± 12.74 years in the treatment failure group (p = 0.001). While 67.6% of the eyes in the treatment success group had monocanalicular obstruction (monocanalicular silicone tube applied), 66.7% of those in the treatment failure group had bicanalicular obstruction (bicanalicular silicone tube applied) (p = 0.049). The most common distal obstruction was seen in the treatment success group, and the least distal obstruction and the most proximal obstruction were observed in the treatment failure group (p < 0.001). The mean duration silicone tube stay was 9.37 ± 1.96 months in the treatment success group and 7.25 ± 1.42 months in the treatment failure group (p = 0.003).

Conclusion

We consider that trephination with the use of a monocanalicular or bicanalicular silicone tube depending on the number of affected canaliculi can be the first choice of treatment in canalicular obstruction due to its high success rate, especially in distal obstruction.
Literatur
1.
Zurück zum Zitat Shin JH, Kim YD, Woo KI (2015) Korean society of ophthalmic plastic and reconstructive surgery (KSOPRS). Impact of epiphora on vision-related quality of life. BMC Ophthalmol. 15:6CrossRefPubMedPubMedCentral Shin JH, Kim YD, Woo KI (2015) Korean society of ophthalmic plastic and reconstructive surgery (KSOPRS). Impact of epiphora on vision-related quality of life. BMC Ophthalmol. 15:6CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Ali MJ, Paulsen F (2020) Human lacrimal drainage system reconstruction, recanalization, and regeneration. Curr Eye Res. 45:241–252CrossRefPubMed Ali MJ, Paulsen F (2020) Human lacrimal drainage system reconstruction, recanalization, and regeneration. Curr Eye Res. 45:241–252CrossRefPubMed
3.
Zurück zum Zitat Everman KR, Czyz CN, Kalwerisky K, Hill RH, Foster JA, Cahill KV (2012) Canalicular obstruction: a histopathologic case series. Can J Ophthalmol 47:500–503CrossRefPubMed Everman KR, Czyz CN, Kalwerisky K, Hill RH, Foster JA, Cahill KV (2012) Canalicular obstruction: a histopathologic case series. Can J Ophthalmol 47:500–503CrossRefPubMed
4.
Zurück zum Zitat Athanasiov PA, Madge S, Kakizaki H, Selva D (2011) A review of bypass tubes for proximal lacrimal drainage obstruction. Surv Ophthalmol 56:252–66CrossRefPubMed Athanasiov PA, Madge S, Kakizaki H, Selva D (2011) A review of bypass tubes for proximal lacrimal drainage obstruction. Surv Ophthalmol 56:252–66CrossRefPubMed
5.
Zurück zum Zitat Rea IM, Gibson DS, McGilligan V, McNerlan SE, Alexander HD, Ross OA (2018) Age and age-related diseases: role of inflammation triggers and cytokines. Front Immunol 9:586CrossRefPubMedPubMedCentral Rea IM, Gibson DS, McGilligan V, McNerlan SE, Alexander HD, Ross OA (2018) Age and age-related diseases: role of inflammation triggers and cytokines. Front Immunol 9:586CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Ozer O, Eskiizmir G, Unlü H, Işisağ A, Aslan A (2012) Chronic inflammation: a poor prognostic factor for endoscopic dacryocystorhinostomy. Eur Arch Otorhinolaryngol 269:839–845CrossRefPubMed Ozer O, Eskiizmir G, Unlü H, Işisağ A, Aslan A (2012) Chronic inflammation: a poor prognostic factor for endoscopic dacryocystorhinostomy. Eur Arch Otorhinolaryngol 269:839–845CrossRefPubMed
7.
Zurück zum Zitat Zadeng Z, Singh M, Singh U (2014) Role of lacrimal canalicular trephination and mini-monoka stent in the management of idiopathic distal canalicular obstructions: our experience of 23 Cases. Asia Pac J Ophthalmol (Phila) 3:27–31CrossRefPubMed Zadeng Z, Singh M, Singh U (2014) Role of lacrimal canalicular trephination and mini-monoka stent in the management of idiopathic distal canalicular obstructions: our experience of 23 Cases. Asia Pac J Ophthalmol (Phila) 3:27–31CrossRefPubMed
8.
Zurück zum Zitat Khoubian JF, Kikkawa DO, Gonnering RS (2006) Trephination and silicone stent intubation for the treatment of canalicular obstruction: effect of the level of obstruction. Ophthalmic Plast Reconstr Surg 22:248–252CrossRefPubMed Khoubian JF, Kikkawa DO, Gonnering RS (2006) Trephination and silicone stent intubation for the treatment of canalicular obstruction: effect of the level of obstruction. Ophthalmic Plast Reconstr Surg 22:248–252CrossRefPubMed
9.
Zurück zum Zitat Kaufman LM, Guay-Bhatia LA (1998) Monocanalicular intubation with Monoka tubes for the treatment of congenital nasolacrimal duct obstruction. Ophthalmology 105:336–341CrossRefPubMed Kaufman LM, Guay-Bhatia LA (1998) Monocanalicular intubation with Monoka tubes for the treatment of congenital nasolacrimal duct obstruction. Ophthalmology 105:336–341CrossRefPubMed
10.
Zurück zum Zitat Satchi K, McNab AA (2019) Idiopathic acquired lacrimal canalicular obstruction. Ophthalmic Plast Reconstr Surg 35:266–268CrossRefPubMed Satchi K, McNab AA (2019) Idiopathic acquired lacrimal canalicular obstruction. Ophthalmic Plast Reconstr Surg 35:266–268CrossRefPubMed
11.
Zurück zum Zitat Nathoo NA, Rath S, Wan D, Buffam F (2013) Trephination for canalicular obstruction: experience in 45 eyes. Orbit 32:281–284CrossRefPubMed Nathoo NA, Rath S, Wan D, Buffam F (2013) Trephination for canalicular obstruction: experience in 45 eyes. Orbit 32:281–284CrossRefPubMed
Metadaten
Titel
Trephination and silicone tube intubation in the treatment of canalicular obstruction
verfasst von
Berna Sahan
Ferda Ciftci
Publikationsdatum
17.08.2022
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 2/2023
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-022-02453-9

Weitere Artikel der Ausgabe 2/2023

International Ophthalmology 2/2023 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.